pembrolizumab
merck
['pembro', 'kn-564', 'rcc,(-irccs),(-srcc),(-urcc)']
kn-564:adjuvant pembro in high risk rcc
overall survival: do we need to wait?
by james larkin #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni